Drug Trial Radar · NCT05515770
The Implementation of Pre-exposure Prophylaxis of Injectable Cabotegravir
Last checked: Nov 19, 2026Latest source record: Oct 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
1,200
Planned (sponsor's estimate)
Start
Sep 20, 2022
Primary completion
Oct 2025
Study completion Feb 2026
Sponsor
- Lead sponsor
- Evandro Chagas National Institute of Infectious DiseaseAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Beatriz Grinsztejn; Thiago Torres; Valdilea Gonçalves; Brenda Hoagland
- First posted
- Aug 25, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- Male only, from 18 years, up to 30 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Although CAB LA PrEP has been proven efficacious in blinded randomized controlled clinical trials, additional research is needed to evaluate effectiveness in real world settings as well as to identify effective implementation strategies. The proposed implementation study will assess the safety and effectiveness of open label CAB LA PrEP when offered at public health facilities to cisgender men and transgender or gender non-binary individuals who have sex with persons assigned male at birth. The study will also evaluate two nested implementation strategies, an mHealth education and decision support tool and a WhatsApp injection appointment reminder. The study will also assess overall facilitators and barriers to integrating CAB LA into existing oral PrEP services.
Conditions
- HIV Infections
Interventions
Cabotegravir InjectionDrug
Long action cabotegravir injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incident HIV infectionTime frame: 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Instituto Nacional de Infectologia Evandro Chagas/ FIOCRUZ
Rio de Janeiro, Brazil · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.